Feb 19, 2019 7:00 am EST Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26
Feb 14, 2019 7:00 am EST Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
Feb 6, 2019 7:00 am EST Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan
Feb 4, 2019 4:05 pm EST Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck